Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2] · 8.8H2O and [Cu(4-Mecdoa)(phen)2] · 13H2O (phen = 1,10-phenanthroline)

Journal of Inorganic Biochemistry

Volumn 101, Issue 8, 2007, Pages 1108-1119

  Creaven, Bernadette S ^a   Egan, Denise A ^a   Karcz, Dariusz ^a   Kavanagh, Kevin ^a,b   McCann, Malachy ^a,b   Mahon, Mary ^c   Noble, Andy ^a   Thati, Bhumika ^a   Walsh, Maureen ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c University of Bath   (United Kingdom)

Author keywords

1,10 Phenanthroline; Antimicrobial; Copper(II); Coumarin 6,7 dioxyacetic acid; Manganese(II); X ray structure

Indexed keywords

4 METHYLCOUMARIN 6,7 DIOXYACETIC ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COPPER COMPLEX; COPPER(4 METHYLCOUMARIN 6,7 DIOXYACETIC ACID)(1,10 PHENANTHROLINE)2; COPPER(COUMARIN 6,7 DIOXYACETIC ACID)(1,10 PHENANTHROLINE)2; COUMARIN 6,7 DIOXYACETIC ACID; KETOCONAZOLE; MANGANESE; MANGANESE(4 METHYLCOUMARIN 6,7 DIOXYACETIC ACID); MANGANESE(COUMARIN 6,7 DIOXYACETIC ACID); UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CHLORATES; COPPER; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; ERGOSTEROL; ESCHERICHIA COLI; MANGANESE; PHENANTHROLINES; STAPHYLOCOCCUS AUREUS; UMBELLIFERONES; WATER;

CANDIDA; CANDIDA ALBICANS; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 34447093461     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2007.04.010     Document Type: Article

References (64)

1. Zetola N., Francis J.S., Nuermberger E.L., and Bishai W.R. Lancet Infect. Dis. 5 (2005) 275-286
2. Simor E.A., Ofner-Agostini M., and Bryce E. Can. Med. Assoc. J. 165 (2001) 21-26
3. Khairulddin N., Bishop L., and Lamagni T.L. Arch. Dis. Child. 89 (2004) 378-389
4. Gray J.W. Arch. Dis. Child. 89 (2004) 297-298
5. Dietrich D.W., Auld D.B., and Mermel L.A. Pediatrics 113 (2004) e347-e352
6. Isaacs D., Fraser S., Hogg G., and Li H.Y. Arch. Dis. Child. 89 (2004) F331-F335
7. Kaplan S.L., Hulten K.G., and Gonzalez B.E. Clin. Infect. Dis. 40 (2005) 1785-1791
8. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., and Wenzel R.P. Clin. Infect. Dis. 29 (1999) 239-244
9. Beck-Sague C., and Jarvis W.R. J. Infect. Dis. 167 (1993) 1247-1251
10. Calderone R.A., and Candida and Candidiasis (2002), ASM press, Washington
11. Akins R.A. Med. Mycol. 43 (2005) 285-318
12. Sanglard D. Curr. Opin. Microbiol. 5 (2002) 379-385
13. Kontoyiannis D.P., and Lewis R.E. Lancet 359 (2002) 1135-1144
14. Ghannoum M.A., and Rice L.B. Clin. Microbiol. Rev. 12 (1999) 501-517
15. Rogers R. Int. J. Antimicrob. Agents 27 (2006) 7-11
16. Chamilos G., and Kontoyiannis D.P. Drug Resist. Update 8 (2005) 344-358
17. Francois E., Aerts A.M., Cammue B.P., and Thevissen K. Curr. Drug Targets 6 (2005) 895-907
18. Coyle B., Kavanagh K., McCann M., Devereux M., and Geraghty M. Biometals 16 (2003) 321-329
19. Nath M., Jairath R., Eng G., Song X., and Kumar A. J. Organomet. Chem. 690 (2005) 134-144
20. Kostova I., Momekov G., Zaharieva M., and Karaivanova M. Eur. J. Med. Chem. 40 (2005) 542-551
21. Kostova I., Manolov I., and Momekov G. Eur. J. Med. Chem. 39 (2004) 765-775
22. Kostova I., Manolov I., and Karaivanova M. Acta. Pharm. Pharm. Med. Chem. 334 (2001) 157-162
23. Kostova I., Manolov I., Nicolova I., Konstantinov S., and Karaivonova M. Eur. J. Med. Chem. 36 (2001) 339-347
24. Kostova I., Manolov I., Nicolova I., and Danchev N. Il Farmaco 56 (2001) 707-713
25. Finn G., Creaven B.S., and Egan D.A. Melanoma Res. 11 (2001) 461-467
26. Finn G., Creaven B.S., and Egan D.A. Cancer Lett. 183 (2002) 61-68
27. Finn G., Creaven B.S., and Egan D.A. Cancer Lett. 205 (2004) 69-79
28. Finn G., Creaven B.S., and Egan D.A. Eur. J. Pharm. Sci. 26 (2005) 16-25
29. Finn G., Creaven B.S., and Egan D.A. Cancer Lett. 214 (2004) 43-54
30. Finn G., Creaven B.S., and Egan D.A. Biochem. Pharm. 67 (2004) 1779-1788
31. Finn G., Creaven B.S., and Egan D.A. Eur. J. Pharmacol. 481 (2003) 159-167
32. Creaven B.S., Egan D.A., Kavanagh K., McCann M., Mahon M., Noble A., Thati B., and Walsh M. Polyhedron 24 (2005) 949-957
33. Creaven B.S., Egan D.A., Kavanagh K., McCann M., Mahon M., Noble A., Thati B., and Walsh M. Inorg. Chim. Acta 359 (2006) 3976-3984
34. Sheldrick G.M. ShelX-86, Program for the Solution of Crystal Structures (1986), University of Göttingen, Germany
35. Sheldrick G.M. ShelX-97, Program for Crystal Structure Refinement (1997), University of Göttingen, Germany
36. Arthington-Skaggs B.A., David W.W., and Christine J.M. Antimicrob. Agent Chemother. 44 (2000) 2081-2093
37. Deacon G.B., and Philips R.J. Coord. Chem. Rev. 33 (1980) 227-250
38. McCann M., Cronin J.F., Devereux M., McKee V., and Ferguson G. Polyhedron 14 (1995) 3617-3626
39. McCann M., Devereux M., Cardin C., and Convery M. Polyhedron 13 (1994) 221-226
40. Devereux M., McCann M., Cronin J.F., Cardin C., Convery M., and Quillet V. Polyhedron 13 (1994) 2359-2366
41. McCann M., Casey M., Devereux M., Curran M., Cardin C., and Todd A. Polyhedron 15 (1996) 2117-2120
42. Mohamed G.G. Spectrochim. Acta (PartA) 57 (2001) 1643-1648
43. Mehrotra R.C., and Bohra R. Metal Carboxylates (1983), Academic Press, London
44. McCann M., Cronin J.F., Devereux M., and Ferguson G. Polyhedron 14 (1995) 2379-2387
45. Addison A.W., Rao T.N., Reedijk J., van Rijn J., and Verschoor G.C. J. Chem. Soc. Dalton Trans. (1984) 1349-1356
46. Coronado E., Gimenez M.C., Gomez-Garcia C.J., and Romero F.M. Polyhedron 22 (2003) 3115-3122
47. Bian H.D., Xu J.Y., Gu W., Yan S.P., Liao D.Z., Jiang Z.H., and Cheng P. Inorg. Chem. Commun. 6 (2003) 573-576
48. Du M., Cai H., and Zhao X.J. Acta Crystallogr., Sect. E 60 (2004) m1139-m1141
49. McCann M., Geraghty M., Devereux M., O'Shea D., Mason J., and O'Sullivan L. Metal Based Drugs 7 (2000) 185-193
50. Geraghty M., Cronin J.F., Devereux M., and McCann M. Biometals 13 (2000) 1-8
51. McCann M., Coyle B., Briody J., Bass F., Gorman N.O., Devereux M., Kavanagh K., and McKee V. Polyhedron 22 (2003) 1595-1601
52. Devereux M., McCann M., Leon V., Kelly R., O'Shea D., and McKee V. Polyhedron 22 (2003) 3187-3194
53. Dendrinou-Samara C., Psomas G., Christophorou K., Tangoulis V., Raptopoulou V.P., Terzis A., and Kessissoglou D.P. J. Chem. Soc., Dalton Trans. (1996) 3737-3743
54. Psomas G., Dendrinou-Samara C., Philippakopoulos P., Tangoulis V., Raptopoulou C.P., Samaras H., and Kessissoglou D.P. Inorg. Chim. Acta 272 (1998) 24-32
55. Psomas G., Raptopoulou C.P., Iordanidis L., Dendrinou-Samara C., Tangoulis V., and Kessissoglou D.P. Inorg. Chem. 39 (2000) 3042-3048
56. Dendrinou-Samara C., Psomas G., Raptopoulou C.P., and Kessissoglou D.P. J. Inorg. Biochem. 83 (2001) 7-16
57. Krishnamurty C., Bryan L.A., and Petering D.H. Cancer Res. 40 (1980) 4092-4121
58. Takamiya K. Nature 185 (1960) 190
59. Sigman D.S., Mazumder A., and Perrin D.M. Chem. Rev. 93 (1993) 2511-2533
60. Hirohama T., Kuranuki Y., Ebina E., Sugizaki T., Arii H., Chikira M., Selvi P.T., and Palaniandavar M. J. Inorg. Biochem. 99 (2005) 1205-1219
61. Eshwika A., Coyle B., Devereux M., McCann M., and Kavanagh K. Biometals 17 (2004) 415-422
62. McCann M., Coyle B., McKay S., McCormack P., Devereux M., Kavanagh K., McKee V., Kinsella P., O'Connor R., and Clynes M. Biometals 17 (2004) 635-645
63. Geraghty P., and Kavanagh K. Arch. Microbiol. 179 (2003) 295-300
64. Parks L.W., and Casey W.M. Ann. Rev. Microbiol. 49 (1995) 95-116